Treatment Registry
TR-0640 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by NuuVim · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$133

Medication · Injectable Tirzepatide, new to GLP-1s (first 3 months)$133

Added from the figures recorded below.

Price

TermPer monthCharged today
Injectable Tirzepatide, new to GLP-1s (first 3 months)

$133 / month $399 Total First 3 months · 3-month billing plan

source

Per month$133Charged today$399
Injectable Tirzepatide, standard/renewal rate

$199.67 / month $599 Total Standard rate · 3-month billing plan

source

Per month$199.67Charged today$599
Visit NuuVim

We earn nothing from this link. NuuVim has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyHallandale Pharmacy, Fort Lauderdale FL; VialsRX, Houston TX
StatesAll 50 states
PrescriberAsynchronous review
Cancellation“Subscription Services automatically renew based on the billing cycle presented during checkout. You may cancel at any time through the patient portal or emailing: support@NuuVim.com .”

Not yet checked: membership and consult fee.

Recorded from nuuvim.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The Oral Tirzepatide SKU has no enum match (no 'oral tirzepatide' drug type exists on this register); recorded as compounded tirzepatide with form sublingual since the page tags it COMPOUNDED and describes it as a sublingual liposomal liquid, same as Oral Semaglutide.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0640
Readings
1

Related records

What else NuuVim sells

All NuuVim programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). NuuVim compounded tirzepatide (TR-0640). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0640

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.